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To elucidate basic mechanisms underlying neurofeedback we investigated neural
mechanisms of training of slow cortical potentials (SCPs) by considering EEG- and fMRI.
Additionally, we analyzed the feasibility of a double-blind, placebo-controlled design in NF
research based on regulation performance during treatment sessions and self-assessment
of the participants. Twenty healthy adults participated in 16 sessions of SCPs training:
9 participants received regular SCP training, 11 participants received sham feedback.
At three time points (pre, intermediate, post) fMRI and EEG/ERP-measurements were
conducted during a continuous performance test (CPT). Performance-data during the
sessions (regulation performance) in the treatment group and the placebo group were
analyzed. Analysis of EEG-activity revealed in the SCP group a strong enhancement of
the CNV (electrode Cz) at the intermediate assessment, followed by a decrease back to
baseline at the post-treatment assessment. In contrast, in the placebo group a continuous
but smaller increase of the CNV could be obtained from pre to post assessment. The
increase of the CNV in the SCP group at intermediate testing was superior to the
enhancement in the placebo group. The changes of the CNV were accompanied by a
continuous improvement in the test performance of the CPT from pre to intermediate to
post assessment comparable in both groups. The change of the CNV in the SCP group
is interpreted as an indicator of neural plasticity and efficiency while an increase of the
CNV in the placebo group might reflect learning and improved timing due to the frequent
task repetition. In the fMRI analysis evidence was obtained for neuronal plasticity. After
regular SCP neurofeedback activation in the posterior parietal cortex decreased from the
pre- to the intermediate measurement and increased again in the post measurement,
inversely following the U-shaped increase and decrease of the tCNV EEG amplitude
in the SCP-trained group. Furthermore, we found a localized increase of activity in the
anterior cingulate cortex (ACC). Analyses of the estimation of treatment assignment by
the participants indicate feasibility of blinding. Participants could not assess treatment
assignment confidently. Participants of the SCP-group improved regulation capability
during treatment sessions (in contrast to the participants of the placebo-group), although
regulation capability appeared to be instable, presumably due to diminished confidence in
the training (SCP- or sham-training). Our results indicate that SCP training in healthy adults
might lead to functional changes in neuronal circuits serving cognitive preparation even
after a limited number of sessions.
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INTRODUCTION
Local cortical oscillations shape sensory, motor, and cognitive
processes (Rothenberger, 2009). Such changes in neuroelectric
activity are assumed to indicate the excitability of neuronal
networks and have gained increasing interest in the investiga-
tion of mental functioning (e.g., executive functions, especially
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attention research, (Banaschewski and Brandeis, 2007; Calderone
et al., 2014) as well as mental and emotional malfunctioning
(Dennis, 2010; Henderson, 2010). In the search for neuro-
physiological conditions of (child- and adolescent) mental dis-
orders different neuro-psychiatric disorders came into focus
(Banaschewski and Brandeis, 2007). In first line, attention
deficit/hyperactivity disorder (ADHD), epilepsy, and tic-/tourette
disorder appeared to be associated with dysfunctions in the
regulation of cortical excitation (Heinrich et al., 2007). Espe-
cially in children with ADHD, investigation of brain activity
pattern do not only enrich the knowledge of neurophysiolog-
ical concomitants of the disorder (for a review see Albrecht
et al., under review) but built the theoretical background for
neurofeedback as an innovative treatment tool, emerging from
neurophysiological theory to clinical application (Pine, 2009).
Recent randomized controlled trials document efficacy and clini-
cal significance of neurofeedback in children with ADHD (Arns
et al., 2014). Within a pool of different neurofeedback pro-
tocols applied in children with ADHD, SCP-training currently
might be considered the best validated approach in this field
(Mayer et al., 2013). However, mechanisms of action are nei-
ther on the neurobiological nor on the cognitive-behavioral
level elucidated sufficiently (Gevensleben et al., 2014). A com-
bination of EEG- and fMRI methodology within the scope
of this double-blind, placebo-controlled study should give new
insights in neurobiological and psychological mechanisms of SCP
neurofeedback.
Slow cortical potentials (SCPs) are shifts in the cortical electrical
activity lasting from several hundred milliseconds to several
seconds. SCP might be externally triggered or self-induced.
Their moderating impact on information processing has been
demonstrated in numerous studies (Bauer and Nirnberger, 1981;
Birbaumer et al., 1992; Schupp et al., 1994). Negative SCPs are
assumed to reflect lowered thresholds for the excitation of under-
lying neuronal structures, leading to facilitation of processing e.g.,
during states of behavioral or cognitive preparation. Empirical
evidence indicates e. g. accelerated reaction times during task
performance (Lutzenberger et al., 1982; Rockstroh et al., 1982).
Positive SCPs indicate reduction of cortical excitation of the
underlying neural structures (e.g., during behavioral inhibition;
Birbaumer et al., 1990), resulting e.g., in an attenuated startle
reflex (Schupp et al., 1994).
The generation of a contingent negative variation (CNV), a
characteristic negative SCP representing anticipatory attention,
motivation, and motor preparation (Walter et al., 1964; Fan
et al., 2007) relies on the activity of a thalamo-cortical-striatal
circuit encompassing the prefrontal cortex (Rockstroh et al.,
1993; Rosahl and Knight, 1995) primary and supplementary
motor areas (Ioannides et al., 1994), posterior parietal cortex
(Durstewitz, 2004) anterior cingulate cortex (ACC) and thala-
mic nuclei (Nagai et al., 2004). However, distinguishing early
(initial, iCNV) and late (terminal, tCNV) components, different
cortical and subcortical structures are assumed to be involved.
This is indicated by differential source distributions for iCNV
and tCNV in previous EEG studies. While the iCNV seems
strongest at bilateral frontal electrodes, the tCNV appears to
unfold maximum activity at the vertex (Birbaumer et al., 1990).
Further evidence results from a previous trial of our laboratories.
Using a continuous performance test (CPT) with a long inter-
stimulus-interval (ISI) of 6 s, we found evidence for distinct
cortical and subcortical brain regions associated with early and
late components of the CNV (Lütcke et al., 2009). The late
CNV mainly appeared to be associated with activations in the
frontal cortex, dorsal ACC and thalamus and increased activ-
ity in midbrain dopaminergic nuclei (very likely correspond-
ing to the substantia nigra). The initial CNV was localized
mainly in motor and premotor cortical areas and the caudate
nucleus.
Regulation of SCPs appears to be attenuated in children
with ADHD, as indicated by a reduced CNV during CPT tasks
(Banaschewski et al., 2003; Banaschewski and Brandeis, 2007).
Furthermore, several controlled trials demonstrate that SCP
training increases regulation of cortical excitability in terms of an
enhanced post-treatment CNV and reduces ADHD symptoma-
tology (Heinrich et al., 2004; Drechsler et al., 2007; Doehnert
et al., 2008; Gevensleben et al., 2009, 2010; Mayer et al., 2013).
Concerning children with ADHD, a more pronounced CNV
seems to predict better outcome of a SCP training (Wangler et al.,
2011).
Beyond neurobiological considerations, psychological (cogni-
tive behavioral) operators or mechanisms of neurofeedback are
hypothesized, but not empirical validated. Generation of SCP
regulation capability (learning of neuro-regulation of SCPs) is
assumed to rely on operant learning mechanisms, sharing path-
ways with skill motor acquisition (Strehl, this issue; Birbaumer
et al., 2013). In how far effort, attributions, motivation or person-
ality factors contribute to the outcome of SCP treatment is not
sufficiently elucidated, although there is some evidence that there
is an impact of such mental pattern (Gevensleben et al., 2014).
It will take several trials to investigate the selective influence of
distinct cognitive-behavioral (and emotional?) variables on the
efficacy of different neurofeedback protocols. In the short run it
seems important to get a rough idea of the impact of e. g. attri-
butions (expectations, individual evaluations) on the course of
neurofeedback training in order to distinguish valid from invalid
strategies in the evaluation of treatment efficacy of NF. There
is “pestering” request for double-blind, placebo-controlled trials,
although the proof of feasibility in neurofeedback research is
still weak, especially in children with ADHD. The NF-procedures
(protocols and applications) used in those placebo-NF trials have
been criticized for several reasons (inter alia poor treatment
fidelity) and may account for the contradictory outcome (Arns
et al., 2014; Gevensleben et al., 2014). Among other shortcomings
of previous double-blind, placebo-controlled trials, none of the
previous trials in children with ADHD could demonstrate validity
of the treatment design in terms of “learning of neuro-regulation”.
Acquisition of regulation capability during the treatment ses-
sions is considered an indispensable prerequisite for a positive
outcome of training. However, no previous placebo-trial could
demonstrate learning. Contrariwise the latest placebo-trial in
children with ADHD asserted that participant did not learn to
regulate the targeted EEG parameters during treatment sessions
(Vollebregt et al., 2014). Due to the fact that most participants
of placebo-neurofeedback-trials consider the training a placebo
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treatment (even most of the participants of the “real treatment”
group; Lansbergen et al., 2011; van Dongen-Boomsma et al.,
2013) the lack of acquisition of regulation capability might result
from impaired confidence in the treatment credibility during
training.
In order to investigate neurobiological and psychological
mechanisms of action of SCP training, we analyzed the impact
of SCP training on the tCNV and conducted fMRI-whole
brain analysis (parietal cortex ACC) in a CPT with long ISI.
Using electroencephalography (EEG) and functional magnetic
resonance imaging (fMRI) enabled us to investigate neural
correlates of late anticipation (related to negative SCPs) at
high temporal resolution (EEG) and at high spatial resolution
(fMRI).
A second aim was to analyze the relation between the
treatment evaluation (believe to get through a SCP- or placebo-
training) and the acquisition of neuro-regulation capability
during the training sessions.
MATERIALS AND METHODS
SUBJECTS
Twenty healthy adults (age 18–29) participated in a SCP or
sham NF-training, as well as in fMRI and EEG assessments.
All experimental procedures conformed fully the institutional
guidelines. The trial was approved by the local ethics committee
of the University Medical Center Göttingen (UMG). Participants
were informed about the purposes of the study and gave written
informed consent. They were paid 85e for the completion of the
study. All participants were screened for mental/psychiatric dis-
orders with the SKID-I screening questionnaire (Wittchen et al.,
1997) supplemented by the assessment of symptoms of an atten-
tion deficit and hyperactivity disorder (Wender-Utah-Rating-
Scale, short version; WURS-k; Retz-Junginger et al., 2002) and a
general psychopathological profile (symptom-checklist, SCL-90-
R; Leonard and Derogatis, 1994). General cognitive ability (GCA)
was determined by the mean of four subtests of the WAIS-III
(Wechsler, 1997; Table 1). There were no significant differences
between the samples.
PROCEDURE
The study consisted of a SCP training and pre-, intermediate-,
and post- training EEG and fMRI measurements. Subjects were,
in a double-blind procedure, pseudo-randomly assigned to either
Table 1 | Demographic and clinical characteristics of the sample.
Sample SCP (n = 9) Placebo (n = 11)
M (SD) M (SD)
Age (years, month) 23.2 (2.91) 22.9 (2.98)
Sex (female/male) 7/2 7/2
GCA (WAIS-III) 10 (2.56) 10.30 (1.44)
WURS-k (ADHD) 21.44 (9.15) 16.45 (4.30)
SCL-90-R (psychopathology) 0.15 (0.14) 0.29 (0.34)
Description of the sample: GCA = mean of the four subtests vocabulary, bloc
design, similarities, matrix reasoning of the WAIS-III; WURS-k: questionnaire
which assesses symptoms of ADHD in childhood; SCL-90-R: GSI = global
severity score (mean of all symptoms).
real-SCP or sham-SCP training. Both trainings consisted of 16
training units of about 45 min each. Two units, divided by a
short break, were conducted in each training session. The 8
training sessions were spread across 3 weeks, with generally two
to three sessions per week depending on the schedule of the
participants.
EEG- and fMRI-measurement were conducted before the first
session (pre-test), after 4 sessions (intermediate-test), and after
the final session (post-test). EEG measurements were performed
in the EEG laboratory of the Department of Child and Adoles-
cent Psychiatry, University Medical Center, Göttingen (UMG).
FMRI measurements were performed at the Biomedizinische
NMR Forschungs GmbH, Max Planck Institute for Biophysical
Chemistry, Göttingen. The EEG and fMRI measurements at each
time point were conducted within a week.
TREATMENT (TRAINING)
The neurofeedback program SAM (“Self-regulation and Atten-
tion Management”) was used for both the SCP and the sham
training. The SAM-system has been developed by our study
group for scientific purposes and has been employed effectively
in different previous NF studies (Heinrich et al., 2004; Drechsler
et al., 2007; Gevensleben et al., 2009).
SCP training
Within the SAM training units, participants were asked to direct
a ball on a computer screen upwards (negative SCP trials) or
downwards (positive SCP trials) by generating negative or positive
SCPs. All participants were instructed to get into an attentive
(negative SCP trials) or relaxed state (positive SCP trials). Neg-
ative SCP and positive SCP trials were presented with equal
probability in random order. One trial lasted for 8 s (baseline
period: 2 s, feedback period: 6 s), inter-trial-interval was set to
5 ± 1 s. During the feedback phase, the mean SCP amplitude
(moving time window: 1 s) was calculated at a rate of 10 Hz
(10 times per second). Each SCP training unit presented approx-
imately 120 trials and lasted 25–30 min. At least 1/3 transfer
trials were conducted, where no feedback was provided. Transfer
trials are thought to facilitate generalization (Heinrich et al.,
2007).
Feedback was calculated from the Cz electrode, which is
standard for SCP training (Heinrich et al., 2007; reference:
mastoids, bandwidth: 0.01–30 Hz for SCP training, sampling
rate: 250 Hz). Vertical eye movements, recorded from elec-
trodes above and below the left eye, were corrected online
using regression-based algorithms (Kotchoubey et al., 1997).
Artifact thresholds were set to ± 100 µV in the EEG channel
and ± 200 µV in the EOG channel. For segments contain-
ing artifacts exceeding this threshold no feedback was calcu-
lated. However, in individual cases thresholds were adapted
(due to alternating signal quality, primarily at the beginning of
the training) to enable contingent (less artifact-contaminated)
feedback.
Sham training
In placebo training, the feedback data of participants of a previous
study were used, providing an appropriate range of different
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feedback curves. These curves were weighted by coefficients to
control the development of positive and negative SCPs in the
course of the training such that participants should have the
impression of the development of poor, average or good reg-
ulation skills over the course of the training. Three subjects
(one third) of the placebo group were assigned to each of this
“skill impression” group. Different approaches were taken to
guarantee the blindness of the participants as well as of the
trainers towards the training condition. Trainers did not see
the online recorded EEG signal, but only the (real or simu-
lated) feedback curve. Participants also saw the (real or sim-
ulated) feedback curve. For all participants (SCP and sham)
the online recorded EOG signal was shown on the screen dur-
ing the trials and the artifact detection was based in both
training groups on the actual online EEG and EOG signals.
This is considered to be an essential component to guaran-
tee blindness of trainer and participant in a placebo-controlled
study.
ESTIMATION OF TREATMENT ASSIGNMENT
On a five-point-scale (0 = “I strongly agree”; 1 = “I rather agree;
2 = “I don’t know; 3 = I rather disagree; 4 = “I strongly disagree”)
participants rated their estimation of group assignment (“I’m
involved in a regular neurofeedback training”) following each
training sessions. The assessment controls for blinding and/or
differences in the evaluation/estimation of the training. Further-
more the analysis of the guessed treatment assignment allowed
investigating a potential relation between the estimation of the
training and the development of regulation capability in the SCP
group.
NEURO-REGULATION ASSESSMENT AND ANALYSIS
During the training sessions subjects were instructed to generate
shifts of cortical excitability (SCPs) towards positivity (reduced
excitability) or negativity (enhanced excitability). Regulation
indices were calculated as the difference between the EEG-activity
during positivity trials vs. negativity trials, reflecting a measure
of neuro-regulation capability. Due to the slow development of
a SCP, only the last 4 s of the 6-s-feedback-interval of a trial
were taken into account (Hinterberger et al., 2005). Analysis of
regulation capability encompassed regular feedback as well as
transfer trials combined.
The difference in the activity between positivity trials and
negativity trials of one session in terms of a regulation index is
considered as the regulation capability during a session.
The session regulation index describes the difference in the
activity between positivity trials and negativity trials within one
session. The mean regulation index represents the average of the
in-session regulation indices of all 8 training sessions for each
subject.
CONTINUOUS PERFORMANCE TASK (CPT)
In the pre-, intermediate-, and post-training EEG and fMRI
measurements, a cued version of a continuous performance task
(CPT; van Leeuwen et al., 1998; Heinrich et al., 2004) with
an extended stimulus onset asynchrony (SOA) of 6000 msec
was applied. This duration closely corresponds to the standard
duration of SCP trials during training sessions and conforms to
the time resolution of the BOLD fMRI measurements (Lütcke
et al., 2009).
For the CPT, subjects were presented with the letters O, X, or
H. During EEG measurements black letters against a light gray
background were shown in the center of a 17-inch CRT monitor
with 800 × 600 points resolution against a light gray background
at a viewing angle of 1.58 vertically and 1.08 horizontally. For
fMRI measurement a dedicated setup was used (Schaefter and
Kirchhoff, Hamburg, Germany) to project the stimuli on a screen
within the MRI bore. Here black letters against a white back-
ground were presented. Two black vertical bars were continuously
present above and below the stimulus location, to direct subjects’
attention to the center of the screen.
The letters were presented for 250 ms, with an inter stimulus
interval of 5750 ms. The subjects were instructed that the letter
O acted as an attentional signal (cue) and that they should press
a response button as fast as possible with their right thumb or
index finger if the following letter was an X (target) and to refrain
from pressing the response button if the following letter was an
H (distractor). To encourage fast responses, correct responses
(button presses) had to occur within 1000 ms from stimulus
onset. After the measurement subjects received visual feedback
about the percentage of correct responses, as well as their average
reaction time achieved.
A total of 80 stimuli were presented in one measurement (one
block, total duration about 8 min.), the probability of an O-X
pair (cued target) as well as the O-H pair (cued distractor) was
20% each (16 pairs/measurement). Additionally, there was a 10%
chance of an uncued H (non-target) or X being shown. The test
consisted of four blocks with a short break between each block.
EEG RECORDING AND PROCESSING
Electrical activity of the brain was recorded with a BrainAmp
amplifier (Brain Products, Munich, Germany) and sintered
Ag/AgCl electrodes with Abralyt2000 electrolyte from 23 sites
according to an extended 10–20 system (recording reference: FCz,
ground electrode: CPz). Electrooculogram electrodes were placed
above and below the right eye and at the outer canthi. Impedances
of the electrodes were kept below 10 kOhm. Data was sampled at
a rate of 500 Hz (bandwidth: 0.016–120 Hz).
Data were processed with Vision Analyzer software (Brain
Products, Munich, Germany). Brain electrical activity was re-
referenced to the average, and filtered offline with 0.05–30 Hz,
24 dB/oct Butterworth filters. Ocular artifacts were corrected by
the methods described by Gratton et al. (1983). If the amplitude
at any EEG electrode exceeded±100µV, a segment 150 ms before
and 800 ms following was excluded from further analyzes. The
Cue-related averages (−200–6500 ms) included at least 20 sweeps,
and the tCNV was assessed as the mean amplitude 5000–6000 ms
following cue onset at electrode Cz.
fMRI IMAGING AND DATA ANALYSIS
All MRI measurements were conducted at 3T (Siemens Tim Trio,
Erlangen, Germany) using a 12-channel receive-only head coil.
Individual structural T1-weighted MRI datasets were acquired
using a 3D MP-RAGE sequence (1.3× 1× 1.3 mm3, interpolated
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to 1 × 1 × 1 mm3). fMRI was acquired with a single-shot,
gradient-echo EPI sequence (TR = 2000 ms, TE = 36 ms, flip angle
= 70◦, 244 volumes per run) with a spatial resolution of 2 × 2
× 4 mm3 (matrix = 96 × 96, 192 mm FoV, 7/8 parial Fourier,
bandwidth = 1336 Hz/pixel, echo spacing = 0.81 ms). 22 slices
were acquired without gap in an interleaved fashion, positioned
in the transvers-to-coronal plane, approximately parallel to the
body of the corpus callosum and covering the whole cerebrum.
To facilitate registration of fMRI data to the anatomical 3D image,
one EPI volume with the same specifications as the functional
series but with additional slices (36 slices) was acquired at the end
of each fMRI session.
Evaluation of fMRI data was performed using tools from the
FMRIB Software library (FSL).1 Scans were corrected for subject
motion both in k-space (Siemens, Erlangen, Germany) as well as
by image-based registration (Jenkinson et al., 2002). Nonbrain
tissue was removed (Smith, 2002) and all volumes were intensity-
normalized by the same factor and temporally high-pass filtered
(Gaussian-weighted least-squares straight line fitting, with high-
pass filter cutoff at 100 s). Data were smoothed using a Gaussian
kernel of 5 mm FWHM. Boxcar models were convolved with
a Gamma function to take into account temporal properties of
the hemodynamic response (HR). Model fit was estimated by
statistical time-series analysis in the framework of the general
linear model (GLM) and with local autocorrelation correction
(Woolrich et al., 2001).
First level regressors were describing the last 2 s before the
presentation of the next letter in the cue (O-X, O-H) and the
non-cue (H-O, H-X,) trials. Contrast of interests was set up
as cue (32 trials) vs. non-cue trials (24 trials). This contrast
emphasizes brain activation associated with anticipation, since
subjects prepare for a possible reaction after the cue, but have no
need for preparation in the non-cue trials. Contrast images were
spatially normalized to the MNI152 template brain by means of
their respective anatomical scan. Second-level fixed-effect analysis
combined the 4 fMRI measurements within each session on the
individual subject level. To summarize results across all subjects,
mixed-effects group analysis was performed (Beckmann et al.,
2003; Woolrich et al., 2004). Significant activations based on
Z statistic (Gaussianized T/F) images were obtained by cluster
thresholding determined by an initial threshold of Z > 2.3, and
a corrected cluster significance threshold of p = 0.05 (Worsley
et al., 1992). Group contrasts were set to compare brain activation
changes from the pre- and intermediate-, the pre- and the post-,
as well as the intermediate- and the post- measurements (TIME
effect), between the groups of SCP- and placebo-trained subjects
(GROUP effect) and the interaction between the two effects.
EEG DATA ANALYSIS
The mean score of the estimation of the assignment to the treatment
of the 8 training sessions was compared between both groups
(t-test of independent samples) to control for blinding and/or
differences in the evaluation/estimation of the training.
By comparing the difference of the session regulation index of
session 1 with the session regulation index of session 8, intra-group
1www.fmrib.ox.ac.uk
development of regulation capability was analyzed for both
groups (by paired t-tests). Mean regulation performance across
all sessions between both groups was compared by independent
t-test of the mean regulation index between both training groups.
The relation between the mean values of estimation of the
treatment assignment and the mean regulation capability (mean
regulation index) of the participants was analyzed by correlation
analysis as well as the relation between the SCP in negativity trials
in the single training sessions and the tCNV during the EEG-lab
sessions (Pearson correlation coefficient).
CPT performance data (reaction time) in the EEG lab session
and tCNV activation repeated measure ANOVAs (factor time: pre,
int, post) was computed with group (SCP, sham) as between-
subject factor.
Data analyses were performed using PASW Statistics (v.18).
RESULTS
ESTIMATION OF TREATMENT ASSIGNMENT
On a five-point-scale participants rated their estimation of group
assignment. The average rating across all 20 participants was
M = 2.61 (SD = 0.75). Considering the range of the scale from
0–4 (0 = “I strongly disagree to the estimation that I am involved
in neurofeedback training”, 4 = “I strongly agree . . .”), the aver-
age estimation of the participants indicates ambivalence about
the treatment condition. Ratings of both groups did not differ
significantly, neither regarding the mean score across all sessions
[SCP group: M = 2.73 (SD = 0.57), Placebo group: M = 2.52
(SD = 0.89); t = 0.62; p = 0.54)] nor concerning the rating after
the last session, when the estimation of the treatment assignment
should have been established by the participants [SCP group:
MS8 = 2.67 (SD = 0.87); placebo group: MS8 = 2.27 (SD = 1.27);
t = 0.79. p = 0.44]. In the end, across both groups, no change
in the estimation of group affiliation across the sessions resulted
[MANOVA: factor time: F = 0.66. p = 0.62; factor group: F = 0.24,
p = 0.63; time × group: F = 0.87. p = 0.49]. Figure 1 illustrates
the ratings of the SCP- and the placebo group across all sessions.
Three subjects of the placebo group and no subject of the SCP
group scored below “2” in the mean estimation of treatment
assignment.
SCP-REGULATION PERFORMANCE
For two subjects of the placebo group, session regulation data
were lost due to hard disk problems. The analysis therefore
encompassed SCP group = placebo group = 9 subjects. Due
to organizational problems two subjects of the placebo group
conducted only seven double-sessions. For these cases we chose
a last-observation-carried-forward-approach (LOCF).
Find mean positivity and negativity for each session and ses-
sion regulation indices in Table 2. Comparison of SCP amplitudes
during positivity trials vs. negativity trials during the first session
revealed no significant difference between both conditions, nei-
ther for the SCP group (Mpos1 = 7.83; SD = 7.31; Mneg1 = 3.42;
SD = 5.98; t = 1.16. p = 0.28) nor for the placebo group
(Mpos1 = 10.16; SD = 8.78; Mneg1 = 13.35; SD = 17.24; t = 0.77.
p = 0.47). For the 8th session, a significant difference between
positivity and negativity trials could be obtained in the SCP group
(Mpos8 = 6.84; SD = 7.31; Mneg8 = −0.32; SD = 7.47; t = 2.73,
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FIGURE 1 | Ratings (confidence intervals 95%) of the participants of how convinced they are to be involved in a true SCP training (in contrast to
placebo training).
Table 2 | Regulation performance during SCP training sessions.
Session Regulation indices (µV) sessions 1–8
SCP group (n = 9) Placebo group (n = 9) Contrast
Pos. (SD) Neg. (SD) Reg. (SD) Pos. (SD) Neg. (SD) Reg. (SD) Diff (p)
1 7.83 (7.31) 3.42 (5.98) 4.41 (11.37) 10.16 (8.78) 13.35 (17.24) −3.19 (12.48) 7.60 (0.20)
2 3.29 (9.95) 0.69 (8.02) 2.60 (5.23) 7.45 (13.78) 6.40 (10.10) 1.05 (5.81) 1.55 (0.48)
3 2.15 (5.73) 1.83 (8.90) 0.32 (7.36) 5.58 (13.16) 8.68 (11.10) −3.10 (5.95) 3.42 (0.16)
4 1.12 (8.31) −3.51 (5.01) 4.64 (8.63) 3.06 (10.28) 5.38 (11.02) −2.32 (5.05) 6.96 (0.05)
5 4.88 (7.41) 0.76 (8.23) 4.12 (5.61) 10.39 (17.10) 13.58 (17.05) −3.19 (11.35) 7.32 (0.10)
6 −1.53 (3.03) −1.08 (6.00) −0.45 (6.87) 6.97 (11.71) 7.52 (8.29) −0.54(6.07) 0.09 (0.98)
7 5.40 (5.63) −1.22 (7.28) 6.62 (8.12) 1.96 (8.28) 4.10 (5.18) −0.52 (6.82) 7.14 (0.06)
8 6.84 (8.84) −0.32 (7.47) 7.16 (7.86) 6.35 (7.74) 5.79 (5.92) 1.82 (6.69) 5.34 (0.14)
Comparison of positivity trials, negativity trials, and session regulation indices (positivity trials − negativity trials) between both training groups for each session.
Positive values of the regulation-indices indicate differences between negativity and positivity trials in the desired direction.
p = 0.026) but not in the placebo group (Mpos8 = 8.92; SD = 12.16;
Mneg8 = 7.10; SD = 8.08; t = 0.82, p = 0.44).
Comparing the mean regulation index (positivity—negativity
trials across all sessions) reveals a significantly enhanced regu-
lation capability in the SCP group (Mreg = 3.68, SD = 5.03)
compared to the placebo group (Mreg =−1.25, SD = 3.85; t = 2.33,
p = 0.03).
Differences in regulation capability primarily result from
enhanced activity during negativity trials in the SCP group
(illustrated in Figure 2). There is no difference in mean activity
during positivity trials across all sessions between both training
groups (SCP group: Mpos = 3.75, SD = 3.15; placebo group:
Mpos = 7.28, SD = 10.83), t = 0.94, p = 0.36), but significant more
negativity during negativity trials in the SCP-group (SCP group:
Mneg = 0.07, SD = 4.38; placebo group: Mneg = 8.53, SD = 9.56;
t = 2.41, p = 0.03). Altogether, regulation capability evolves only
in the SCP group and results from enhanced regulation toward
negativity in negativity trials.
INTERRELATION OF REGULATION CAPABILITY AND ESTIMATION OF
TREATMENT ASSIGNMENT
No significant relation between general regulation capability
(mean regulation index) and mean estimation of group assign-
ment (across all session) could be obtained in the SCP group
(r = 0.04, p = 0.91). Table 3 presents Pearson correlation coef-
ficients between the participants’ ratings of group assignment
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FIGURE 2 | Mean session regulation indices across all sessions
(A) show an increase in the regulation capability in the SCP group
(confidence intervals 95%). In the placebo group no significant
development of regulation capability appears. This appears more
evident in the illustration of the z-transformed (standardized deviation
from the mean) session regulation indices. (B) Changes in regulation
capability across all sessions for positivity trials (C) indicate no
differences between the groups during positivity trials while only the
SCP group develops the capability to generate negativity during
negativity trials (D).
and the regulation performance for each session separately.
No systematic relation between estimation of group assign-
ment and regulation capability could be obtained, excluding
two significant correlation coefficients for the sessions 4 and 5
concerning positivity regulation (session 4) and differentiation
(session 5).
NEUROPHYSIOLOGICAL TEST SESSION: tCNV AND PERFORMANCE
The event-related potential following cue stimuli showed the
expected slow negative tCNV with a maximum at central leads
that terminates with the onset of the next stimulus (see Figure 3).
Exploratory analyses revealed that the maximum was located
at electrode Cz where it was further evaluated. As illustrated
in Figure 3, the tCNV mean amplitude shows distinct changes
during the training course (Time: F(2, 34) = 3.4, ε = 0.96,
p = 0.05, part η2 = 0.17 and Training × Time: F(2,34) = 3.6,
ε = 0.96, p = 0.04, part η2 = 0.18): whilst the Placebo group
(Figure 3A) shows a tendency towards increased tCNV from Pre
to Post assessment, the SCP group demonstrates a significant
increase from Pre to Intermediate, and a significant decrease
from Intermediate to Post, back to the Pre-training level (see
Figures 3B,C).
Eight of nine subjects of the SCP group (but only the half
of the placebo group) exhibited an enhancement of the CNV
in the intermediate testing compared to initial measurement
(pre-training testing), indicating that the intermediate CNV
enhancement in the SCP group does not result from separate
outliers.
Moderate to strong relations (correlation coefficients between
0.5 and 0.6) between the regulation performance (SCP during
negativity trials) during single training session and the tCNV in
the EEG-lab sessions developed, which however did not turn out
to be significant due to the small sample size.
Response speed of correct responses showed a steady increase
from pre to intermediate to the post assessment (Time:
F(2,34) = 7.5, ε = 0.76, p< 0.01, part η2 = 0.31), which was similar
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Table 3 | Correlation coefficients between rating of group assignment and regulation performance in the SCP group.
n = 9 Rating session 1–8: correlation (p)
Regulation 1 2 3 4 5 6 7 8
Positivity −0.38 (0.32) 0.50 (0.17) −0.41 (0.27) 0.83 (0.01) 0.58 (0.10) 0.40 (0.28) 0.04 (0.92) 0.27 (0.49)
Negativity 0.46 (0.21) 0.58 (0.10) −0.18 (0.64) 0.24 (0.53) 0.02 (0.95) 0.27 (0.48) −0.27 (0.48) 0.51 (0.16)
Differentiation −0.48 (0.19) 0.05 (0.89) −0.10 (0.80) 0.24 (0.53) 0.74 (0.02) −0.06 (0.88) 0.27 (0.48) −0.19 (0.63)
Pearson correlation coefficients for the SCP group between regulation performance (positivity, negativity, and differentiation = positivity − negativity) and the
subjective ratings of the participants guessing the group assignment (SCP vs. placebo condition).
FIGURE 3 | Top: Time course of the brain electrical activity related to cue
processing at site Cz from the Placebo (A) and SCP (B) training groups at
pre-training (black), intermediate (red) and post-training (green)
assessment. The tCNV is assessed in the time window 5 to 6 s following
cue onset and shows a central maximum. Bottom: Confidence intervals
of tCNV and reaction-time (RT) with p = 0.05 for the comparison between
Placebo and SCP training groups. The tCNV (with p = 0.05) displays a
distinct time course throughout assessments: the Placebo training group
exhibits as a tendency a steady increase in amplitude from pre-training to
post-training assessment, whilst the SCP training group shows an
inverted U-like shift with a significant and homogenous maximum at the
Intermediate assessment (C). Response speed became faster in later
assessments in both training groups (D) CPT-performance in the
neurophysiological test session was characterized by a generally high
accuracy with on average less than 1.5% of omission and commission
error rates in both SCP and Placebo training groups.
for SCP and Placebo training (Training: F(1,17) < 1, p > 0.91,
part η2 < 0.01, Training × Time: F(2,34) < 1, ε = 0.76, p = 0.76,
part η2 < 0.01). There was further a marginal trend for an
interaction “Block × Training” (F(2,34) = 2.2, ε = 0.78, p = 0.12,
part η2 = 0.11), but post hoc tests revealed no clear differences
in time-on-task effects across training groups. See Figure 3B for
further details.
Response speed variability (RT-SD) was lower in the first
compared to the later three blocks (Block: F(3,48) = 2.8, ε = 0.81,
p = 0.06, part η2 = 0.15), but did not reveal any further effects (all
p > 0.18).
FUNCTIONAL MRI
fMRI BOLD-activation of the last two seconds of the CPT antic-
ipation phase was compared between SCP-trained and placebo-
trained group for the three time points (pre, intermediate, post).
All three analyses (pre vs. intermediate, intermediate vs. post,
pre vs. post) showed no significant TIME × GROUP interaction
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FIGURE 4 | BOLD-activation changes in the SCP-trained group
across the training. Top: BOLD-activation higher in the pre- compared
to the intermediate measurement. Middle: BOLD-activation higher in
the post- compared to the intermediate measurement. Bottom:
BOLD-activation higher in the post- compared to the pre- measurement.
R = right.
in brain activation. However, computing within-group contrasts,
three different BOLD-activation patterns became visible within
the group of SCP-trained subjects (Figure 4) whereas no sig-
nificant changes could be seen in the placebo group. In the
comparison of the pre- and the intermediate measurement the
SCP group showed lower BOLD-activation in the right parietal
cortex (postcentral gyrus, peak coordinates: x = 50, y = −28,
z = 56) and insular cortex (x = 32, y = 14, z =−4) at the Interme-
diate measurement. In the intermediate to post comparison, the
BOLD-activation in the right and left parietal cortex (postcentral
gyrus right: x = 48, y =−28, z = 48, postcentral gyrus left: x =−58,
y = −16, z = 20) and insular cortex (x = 34, y = 16, z = 2) was
again lower during the intermediate measurement. The pre-to-
post comparison revealed a distinct increase in BOLD activation
in the ACC (left ACC x = 0, y = 14, z = 40, right ACC x = 2, y = 20,
z = 36) in the post measurement, which could also be detected in
the overall pre-to-post comparison incorporating both, the SCP-
and the placebo-group (main effect TIME).
DISCUSSION
NEURONAL PLASTICITY: tCNV, fMRI, AND PERFORMANCE
At the electrophysiological level we found a result somehow
contrary to our primary expectations. The pre- to intermedi-
ate assessment in the SCP group revealed—according to our
expectations—a strong increase of the tCNV during the CPT in
the EEG-lab sessions. This increase in the SCP group significantly
exceeded the increase of the tCNV in the placebo group. This
enhancement of the parameter targeted by the SCP training (pri-
marily related to negativity trials) was followed by a coequal tCNV
decrease in the post-training assessment in the SCP group (back
to baseline). Interestingly, this inverted U-like shift of the tCNV
in the SCP group was accompanied by a continuing decrease in
reaction time during CPT performance from pre- to intermedi-
ate assessment and from intermediate to post assessment. The
continuing improvement in reaction time was comparable to the
decrease of the reaction time in the placebo group. In contrast, in
the placebo group the tCNV (as the assumed associated parameter
of the performance on the neurophysiological level) showed a
continuing increase in accordance with the decreasing reaction
time. It appears that in the placebo group the increasing mobiliza-
tion of neurophysiological resources (enhancement of the tCNV)
is accompanied by coinciding improvement in the test perfor-
mance (decreasing reaction time). Obviously the participants
of the sham-group learned to optimize their CPT-performance,
mobilizing more neurophysiological resources to continuously
improve performance (learning/repetition effects). On the other
hand, in the SCP group, the continuing improvement in reaction
time is accompanied by an initial increase in the mobilization of
neurophysiological resources in case of an enhanced tCNV in the
intermediate testing, followed by reduction of neurophysiological
effort accompanied by a further enhancement of the performance.
Hence, it may be that subjects conducting SCP training require
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less neurophysiological resources to achieve a comparable perfor-
mance in the long run (at post-training assessment).
This interpretation is in accordance with observations con-
cerning e.g., professional musicians or elite athletes engaged
in highly over-learned motor skill tasks. Long term practic-
ing motor performance might lead to a more efficient gen-
eration of neural activity (reduced or more focused activity
accompanying improvements in performance). In professional
piano players motor areas were activated to a lesser degree dur-
ing finger tapping tasks than in non-musicians (Jäncke et al.,
2000; Krings et al., 2000). The same was true for Neymar
(one of the most esteemed soccer players today), recruiting
less resources in the motor-cortical regions controlling foot
movement compared to less trained soccer players or athletes
of other sporting disciplines, executing a simple foot move-
ment task (Naito and Hirose, 2014).2 From the perspective
of an athlete, this leaves a greater extent of motor cortical
resources for accompanying or concurring motor tasks during the
competition.
The decrease of the tCNV in the SCP group in the post-
training assessment (compared to the intermediate testing) there-
fore might reflect the lesser effort which is needed after NF
training to fulfill the same task with comparable adequacy. For the
same task lesser neurons need to be activated (Krings et al., 2000).
Hence, the same way that long term motor skill training induces
plastic change in central motor systems, SCP training in healthy
humans might result in reorganization of the cortical resource
management, presumably leaving more resources for additional
challenges.
Generally, the tCNV is considered to be associated with the
negative SCPs which have to be generated during the SCP-
sessions (Heinrich et al., 2004). We found some further support
for this notion. The tCNV seemed to appear in relation to the
development of the regulation performance during the training
as indicated by moderate to strong (although non-significant)
correlations between SCPs during negativity trials within the
training sessions and the tCNV during EEG-lab sessions.
The development of the tCNV in the time course of this trial
reveals results from previous trials studying the effects of SCP
training in children with ADHD in a different light. The usual
finding of SCP trials with children with ADHD is an enhanced
(or less reduced) CNV after SCP training (Heinrich et al., 2004;
Doehnert et al., 2008; Wangler et al., 2011). These are findings
corresponding to the result of the intermediate assessment of
our present trial with healthy adults. However, SCP regulation is
impaired in children with ADHD (Banaschewski and Brandeis,
2007) so this might indicate, that even more sessions than usually
practiced in research trials are necessary in children with ADHD
to (firstly acquire an adequate regulation capability and) finally
reach significant optimization on the neurophysiological level (on
the other hand one might speculate that this optimization is
seriously impaired in children with ADHD and might therefore
not result even after a larger number of training sessions).
2This provides empirical evidence for the general impression that professional
soccer players often do not make much use of their mental resources (at least
while executing their complex movement patterns).
The additional whole brain data of the complementary fMRI
CPT measurements may provide additional indications for the
interpretation of the EEG results. Even if no significant difference
in the GROUP× TIME interaction of the BOLD-activation could
be detected between the groups of SCP- and placebo-trained
subjects, significant changes in brain activation can be seen in
the SCP-group across the time course of the training (within
group contrasts) but not in the placebo-group. In the posterior
parietal cortex activation, peaking at the right postcentral sulcus,
decreases from the pre- to the intermediate measurement and,
in the posterior parietal cortex of both hemispheres, increases
again in the post measurement. This pattern inversely follows the
U-shaped increase and decrease of the tCNV EEG amplitude in
the SCP-trained group. Since the posterior parietal cortex is a
multisensory motor association area, involved in motor planning
(Andersen and Buneo, 2002), this change in BOLD-activation
could reflect an aspect of the initial acquisition (pre to interme-
diate) and the following optimization process (intermediate to
post) of the more efficient use of the neurophysiological resources.
However, this interpretation should be taken with precaution,
because these results are not significant in the overall GROUP
× TIME interaction. The pre to post measurement increase in
ACC BOLD-activation in the SCP-trained group, which is also
seen in the overall contrast (main effect TIME), adds another
facet, probably being more related to the changes induced by feed-
back processing during completing a neurofeedback (or placebo-
) training. The ACC, being part of the decision making process
in the frontal cortex (Rushworth et al., 2012), is also known to
be specifically involved in processing of feedback signals to select
the response, which is followed by a reward (Amiez et al., 2012;
Rushworth et al., 2012). However, this change in ACC-activity was
found in both groups and could therefore also reflect learning-
/repetition effects of the CPT.
Taken together, for the SCP trained group, these BOLD-
activation changes in two different areas of the brain, although
being on the level of indications, provide some incidence that a
successful training could not only involve multiple brain areas,
but also encompass changes in different brain networks at differ-
ent levels of optimization.
BLINDING, ESTIMATION OF TREATMENT ASSIGNMENT, AND
REGULATION CAPABILITY
There is controversy about the feasibility of placebo-controlled
trials in NF research. Firstly, previous trials failed to keep up
blinding throughout the training and blinding came into ques-
tion in placebo controlled NF (Holtmann et al., 2014) just as
in psychopharmaceutical research, where as well blinding often
might fail (Margraf et al., 1991; Morin et al., 1995). However,
at least single-/double-blind, placebo controlled trials have been
conducted with promising results concerning the application of
blinding (and placebo control) in NF (Berner et al., 2006; Schabus
et al., 2014). Secondly, placebo-control may affect fidelity of the
training, e.g., diminish the credibility of the training or the effort
spent by the participant (Gevensleben et al., 2012).
The estimations of our participants concerning the guessing of
the treatment assignment display successful blinding. The estima-
tion does not differ between SCP- and sham-training. The mean
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rating close to the middle of the rating scale reflects indecisiveness
of the participants with little variance in the estimation. No
significant correlation between estimation of group assignment
and regulation performance could be obtained, making a signifi-
cant influence of the estimation of the participants (as expected)
quite improbable. However, there was not much variance in the
estimations, making it hard to obtain an assumed connectivity
between estimation and regulation capability. In further trials
we would prefer to manipulate the estimation of the treatment
directly (e.g., via opposed instructions).
Anecdotally we would like to note, that at least one participant
(of the placebo-group) reported after completion of the trial that
he was quite sure, that he had practiced placebo-training. He
delineated his strategy that he once in a while reversed his regula-
tion strategies but could not observe any systematic change in his
displayed feedback following his switch of strategy. Additionally
this underlines possible problems inherent in placebo-control
in NF-research, participants spending effort in elucidating treat-
ment assignment rather than struggling for enhanced regulation
capability.
As expected, regulation capability developed differently in
the SCP- compared to the placebo-group. While there was no
difference in the generation of positivity during positivity trials
between groups, the SCP-group learned to enhance negativity
during the negativity trials (in contrast to the placebo-group).
However there resulted no linear increase in regulation capability.
Regulation performance in the SCP-group appeared to be instable
with no significant differences in the regulation indices between
SCP- and placebo-group for most of the sessions. However,
acquisition of SCP-regulation capability is difficult (Neumann
and Birbaumer, 2003) and probably further impaired by affected
self-confidence and/or confidence in treatment credibility due to
the implementation of a placebo-condition in this trial.
LIMITATIONS AND CONCLUSIONS
The generalization of our results is limited by different factors
among which we consider the most important the small sample
size, which hardly allows for parametric testing. We consider the
results as very relevant but preliminary and like to underline the
need for replication with stronger sample sizes. The design of the
study is compromised by the many repetitions of the CPT, due
to the separated assessment of the EEG and fMRI measurement.
This makes the test susceptible for learning processes overwriting
or influencing systematic but sensible effects of the training. A
combined EEG-fMRI assessment would significantly reduce the
test repetitions and allow to directly put the EEG- in relation to
the fMRI activity.
Nevertheless we consider these results a further step in
understanding mechanisms of change in NF training, indicating
neuronal plasticity even after a short number of SCP sessions
although learning of SCP regulation does not appear to be opti-
mal, probably due to blinding and uncertainty about the training
condition (SCP or placebo).
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